Get the Stockscreener App
28.61
8.33%
-2.60
After Hours:
28.90
0.29
+1.01%
Tonix Pharmaceuticals Holding Corp stock is traded at $28.61, with a volume of 677.09K.
It is down -8.33% in the last 24 hours and down -52.13% over the past month.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
See More
Previous Close:
$31.21
Open:
$30.51
24h Volume:
677.09K
Relative Volume:
0.50
Market Cap:
$250.79M
Revenue:
-
Net Income/Loss:
$-121.02M
P/E Ratio:
-2.5409
EPS:
-11.26
Net Cash Flow:
$-114.09M
1W Performance:
+7.80%
1M Performance:
-52.13%
6M Performance:
+113.35%
1Y Performance:
+79.15%
1-Day Range:
$28.51
$31.28
1-Week Range:
$24.20
$31.55
52-Week Range:
$7.31
$130.00
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile
Name
Tonix Pharmaceuticals Holding Corp
Sector
Industry
Phone
212-980-9155
Address
26 MAIN STREET, SUITE 101, CHATHAM, NY
Compare TNXP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNXP
Tonix Pharmaceuticals Holding Corp
|
28.61 | 236.59M | 0 | -121.02M | -114.09M | -11.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-18-22 | Initiated | Noble Capital Markets | Outperform |
| Apr-18-19 | Upgrade | ROTH Capital | Neutral → Buy |
| Aug-18-17 | Upgrade | ROTH Capital | Neutral → Buy |
| Sep-07-16 | Downgrade | ROTH Capital | Buy → Neutral |
| Feb-17-16 | Reiterated | Oppenheimer | Outperform |
| Nov-04-15 | Initiated | Cantor Fitzgerald | Buy |
| Jun-12-15 | Initiated | Oppenheimer | Outperform |
| Feb-17-15 | Reiterated | ROTH Capital | Buy |
| Sep-29-14 | Reiterated | ROTH Capital | Buy |
View All
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Latest News
Tonix showcases Phase 3 data for FDA-approved Tonmya at PAINWEEK 2025, eyes launch next quarter - Proactive financial news
Tonix Pharmaceuticals : September 2025 Investor Deck - MarketScreener
Published on: 2025-09-08 16:12:23 - beatles.ru
Tonix Pharmaceuticals Presents Clinical Data on Tonmya™ for the - GuruFocus
Tonix Pharmaceuticals Presents Clinical Data on Tonmya™ for the Treatment of Fibromyalgia at PAINWEEK 2025 - Yahoo Finance
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat
Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared Last Week - MSN
Combining machine learning predictions for Tonix Pharmaceuticals Holding Corp.Wall Street Watch & Safe Capital Growth Tips - Newser
Is Tonix Pharmaceuticals Holding Corp. stock entering bullish territoryJuly 2025 Review & AI Optimized Trade Strategies - Newser
Will Tonix Pharmaceuticals Holding Corp. outperform its industry peersNew Guidance & Technical Pattern Based Buy Signals - خودرو بانک
What technical models suggest about Tonix Pharmaceuticals Holding Corp.’s comebackWeekly Trade Review & Reliable Trade Execution Plans - Newser
Why is Tonix Pharmaceuticals Holding Corp. stock going downStop Loss & AI Based Buy/Sell Signal Reports - خودرو بانک
Using data models to predict Tonix Pharmaceuticals Holding Corp. stock movementSell Signal & Low Drawdown Trading Techniques - Newser
What’s the MACD signal for Tonix Pharmaceuticals Holding Corp.2025 Technical Patterns & Smart Swing Trading Alerts - خودرو بانک
Heatmap analysis for Tonix Pharmaceuticals Holding Corp. and competitorsWeekly Volume Report & Real-Time Market Sentiment Reports - Newser
Is Tonix Pharmaceuticals Holding Corp. benefiting from interest rate changesRate Cut & AI Enhanced Market Trend Forecasts - خودرو بانک
What MACD and RSI say about Tonix Pharmaceuticals Holding Corp.Trade Analysis Summary & Safe Capital Allocation Plans - Newser
Will Tonix Pharmaceuticals Holding Corp. stock go up soonPortfolio Risk Summary & Fast Moving Trade Plans - Newser
Published on: 2025-09-05 01:49:05 - Newser
How to integrate Tonix Pharmaceuticals Holding Corp. into portfolio analysis toolsTake Profit & Risk Adjusted Swing Trade Ideas - Newser
What is the cash position of Tonix Pharmaceuticals Holding Corp.2025 Macro Impact & Fast Moving Trade Plans - خودرو بانک
Using R and stats models for Tonix Pharmaceuticals Holding Corp. forecasting2025 Winners & Losers & Weekly Consistent Profit Watchlists - Newser
Is this a good reentry point in Tonix Pharmaceuticals Holding Corp.Weekly Stock Summary & Consistent Profit Trade Alerts - Newser
Does Tonix Pharmaceuticals Holding Corp. have a sustainable dividendJuly 2025 Retail & Daily Profit Maximizing Tips - خودرو بانک
Can Tonix Pharmaceuticals Holding Corp. expand its profit marginsQuarterly Profit Review & Free Expert Verified Stock Movement Alerts - خودرو بانک
Can volume confirm reversal in Tonix Pharmaceuticals Holding Corp2025 Top Decliners & Free High Return Stock Watch Alerts - Newser
Is it too late to sell Tonix Pharmaceuticals Holding Corp.Chart Signals & Long-Term Investment Growth Plans - Newser
What’s the profit margin of Tonix Pharmaceuticals Holding Corp.Weekly Profit Recap & High Yield Equity Trading Tips - خودرو بانک
What high frequency data says about Tonix Pharmaceuticals Holding Corp.July 2025 Opening Moves & Capital Protection Trade Alerts - Newser
Can machine learning forecast Tonix Pharmaceuticals Holding Corp. recoveryQuarterly Portfolio Report & Long-Term Growth Portfolio Plans - Newser
Is Tonix Pharmaceuticals Holding Corp. meeting your algorithmic filter criteriaJuly 2025 Short Interest & AI Optimized Trading Strategy Guides - Newser
Applying chart zones and confluence areas to Tonix Pharmaceuticals Holding Corp.Market Performance Recap & Safe Entry Momentum Tips - Newser
Is Tonix Pharmaceuticals Holding Corp. stock a smart retirement pickMarket Growth Summary & Daily Volume Surge Trade Alerts - khodrobank.com
Can volume confirm reversal in Tonix Pharmaceuticals Holding Corp.Market Performance Recap & Community Consensus Stock Picks - Newser
Visual trend scoring systems applied to Tonix Pharmaceuticals Holding Corp.July 2025 Pullbacks & Stock Timing and Entry Methods - Newser
Published on: 2025-09-03 01:10:04 - Newser
Will Tonix Pharmaceuticals Holding Corp. rebound enough to break evenJuly 2025 Trends & AI Driven Price Forecasts - Newser
Can momentum traders help lift Tonix Pharmaceuticals Holding Corp.July 2025 Snapshot & Fast Moving Market Watchlists - Newser
Using economic indicators to assess Tonix Pharmaceuticals Holding Corp. potentialDollar Strength & High Conviction Investment Ideas - Newser
Does Tonix Pharmaceuticals Holding Corp. fit your quant trading modelEarnings Growth Summary & Weekly High Conviction Ideas - Newser
Why Tonix Pharmaceuticals Holding Corp. stock is on top investor watchlistsWeekly Stock Report & Free High Return Stock Watch Alerts - Newser
Momentum divergence signals in Tonix Pharmaceuticals Holding Corp. chart2025 Market Trends & Long-Term Growth Stock Strategies - Newser
Is Tonix Pharmaceuticals Holding Corp. affected by consumer sentimentJuly 2025 Final Week & Consistent Profit Trade Alerts - خودرو بانک
Analyzing Tonix Pharmaceuticals Holding Corp. with multi timeframe chartsM&A Rumor & Risk Managed Investment Entry Signals - Newser
Quant Strategy Flags Tonix Pharmaceuticals Holding Corp. for Entry getLinesFromResByArray error: size == 0 - kangso.co.kr
What is Tonix Pharmaceuticals Holding Corp. s 5 year growth outlook2025 Support & Resistance & Stepwise Swing Trade Plans - خودرو بانک
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):